1. 2143 Regorafenib for previously treated metastatic colorectal cancer (mCRC): Results from 683 Italian patients treated in the open-label phase 3B CONSIGN study. (September 2015) Authors: Ciardiello, F.; Falcone, A.; Cascinu, S.; Sobrero, A.; Boni, C.; Barone, C.; Luppi, G.; Maiello, E.; Siena, S.; Zagonel, V.; Carteni, G.; Constanzo, F. Di; Bartolomeo, M. Di; Santoro, A.; Russo, A.; Moscovici, M.; Van Cutsem, E.; Zaniboni, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sorafenib in clinical practice: Pooled analysis of two prospective observational studies in hepatocellular carcinoma (HCC). (10th February 2016) Authors: Di Costanzo, G.G.; D'Angelo, S.; Zolfino, T.; Lorusso, V.; Montesarchio, V.; de Stefano, G.; Sacco, R.; Attili, A.F.; Benedetti, A.; Sansonno, D.; Giannitrapani, L.; Buonadonna, A.; Giovanis, P.; Cabibbo, G.; De Vita, F.; Carucci, P.; Pirisi, M.; Moscovici, M.; Pisconti, S.; Daniele, B. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗